Ignite Creation Date:
2025-12-25 @ 3:37 AM
Ignite Modification Date:
2026-03-08 @ 1:07 AM
Study NCT ID:
NCT00645502
Status:
COMPLETED
Last Update Posted:
2010-04-26
First Post:
2008-03-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet.
Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-06
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2003-07
Completion Date Type:
ACTUAL
First Submit Date:
2008-03-24
First Submit QC Date:
None
Study First Post Date:
2008-03-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-04-22
Last Update Post Date:
2010-04-26
Last Update Post Date Type:
ESTIMATED